Manfred Welslau

Manfred Welslau

UNVERIFIED PROFILE

Are you Manfred Welslau?   Register this Author

Register author
Manfred Welslau

Manfred Welslau

Publications by authors named "Manfred Welslau"

Are you Manfred Welslau?   Register this Author

15Publications

615Reads

21Profile Views

Update Breast Cancer 2019 Part 4 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer.

Authors:
Florian Schütz Peter A Fasching Manfred Welslau Andreas D Hartkopf Achim Wöckel Michael P Lux Wolfgang Janni Johannes Ettl Diana Lüftner Erik Belleville Hans-Christian Kolberg Friedrich Overkamp Florin-Andrei Taran Sara Y Brucker Markus Wallwiener Hans Tesch Tanja N Fehm Andreas Schneeweiss Volkmar Müller

Geburtshilfe Frauenheilkd 2019 Oct 22;79(10):1079-1089. Epub 2019 Oct 22.

Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1055/a-1001-9925DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805214PMC
October 2019

Update Breast Cancer 2019 Part 5 - Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer.

Authors:
Manfred Welslau Andreas D Hartkopf Volkmar Müller Achim Wöckel Michael P Lux Wolfgang Janni Johannes Ettl Diana Lüftner Erik Belleville Florian Schütz Peter A Fasching Hans-Christian Kolberg Naiba Nabieva Friedrich Overkamp Florin-Andrei Taran Sara Y Brucker Markus Wallwiener Hans Tesch Andreas Schneeweiss Tanja N Fehm

Geburtshilfe Frauenheilkd 2019 Oct 22;79(10):1090-1099. Epub 2019 Oct 22.

Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1055/a-1001-9952DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805215PMC
October 2019

Update Breast Cancer 2018 (Part 3) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer.

Authors:
Achim Wöckel Michael P Lux Wolfgang Janni Andreas D Hartkopf Naiba Nabieva Florin-Andrei Taran Friedrich Overkamp Peyman Hadji Hans Tesch Johannes Ettl Diana Lüftner Volkmar Müller Manfred Welslau Erik Belleville Sara Y Brucker Florian Schütz Peter A Fasching Tanja N Fehm Andreas Schneeweiss Hans-Christian Kolberg

Geburtshilfe Frauenheilkd 2018 Nov 26;78(11):1110-1118. Epub 2018 Nov 26.

Department of Gynecology and Obstetrics, Marienhospital Bottrop, Bottrop, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1055/a-0715-2821DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255743PMC
November 2018

Update Breast Cancer 2018 (Part 4) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Treatment Strategies for Advanced Breast Cancer.

Authors:
Volkmar Müller Achim Wöckel Michael P Lux Wolfgang Janni Andreas D Hartkopf Naiba Nabieva Florin-Andrei Taran Peyman Hadji Hans Tesch Johannes Ettl Diana Lüftner Manfred Welslau Erik Belleville Sara Y Brucker Florian Schütz Peter A Fasching Tanja N Fehm Hans-Christian Kolberg Andreas Schneeweiss Friedrich Overkamp

Geburtshilfe Frauenheilkd 2018 Nov 26;78(11):1119-1128. Epub 2018 Nov 26.

OncoConsult Hamburg GmbH, Hamburg, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1055/a-0715-2899DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255740PMC
November 2018

A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia.

Authors:
Tamar Tadmor Manfred Welslau Iwona Hus

Expert Rev Hematol 2018 01 27;11(1):57-70. Epub 2017 Nov 27.

c Department of Clinical Transplantology , Medical University of Lublin , Lublin , Poland.

View Article

Download full-text PDF

 Source
https://www.tandfonline.com/doi/full/10.1080/17474086.2018.1
Publisher Site
http://dx.doi.org/10.1080/17474086.2018.1407645DOI Listing
January 2018

The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape.

Authors:
Peter J Goebell Christian Doehn Carsten Grüllich Viktor Grünwald Thomas Steiner Rainer Ehneß Manfred Welslau

Future Oncol 2017 Jul 19;13(17):1463-1471. Epub 2017 May 19.

Haemato-Onkologische Schwerpunktpraxis am Klinikum Aschaffenburg, Aschaffenburg, Germany.

View Article

Download full-text PDF

 Source
https://www.futuremedicine.com/doi/10.2217/fon-2017-0083
Publisher Site
http://dx.doi.org/10.2217/fon-2017-0083DOI Listing
July 2017

Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.

Authors:
Véronique Diéras David Miles Sunil Verma Mark Pegram Manfred Welslau José Baselga Ian E Krop Kim Blackwell Silke Hoersch Jin Xu Marjorie Green Luca Gianni

Lancet Oncol 2017 06 16;18(6):732-742. Epub 2017 May 16.

San Raffaele Hospital, Milan, Italy.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S1470-2045(17)30312-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531181PMC
June 2017

Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial.

Authors:
Mathias Rummel Ulrich Kaiser Christina Balser Martina Stauch Wolfram Brugger Manfred Welslau Norbert Niederle Christoph Losem Hans-Peter Boeck Eckhart Weidmann Ulrich von Gruenhagen Lothar Mueller Michael Sandherr Lars Hahn Julia Vereshchagina Frank Kauff Wolfgang Blau Axel Hinke Juergen Barth

Lancet Oncol 2016 Jan 5;17(1):57-66. Epub 2015 Dec 5.

Department of Haematology and Oncology, Justus-Liebig Universität, Giessen, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S1470-2045(15)00447-7DOI Listing
January 2016

Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy.

Authors:
Fabian Zohren Ingmar Bruns Sabrina Pechtel Thomas Schroeder Roland Fenk Akos Czibere Georg Maschmeyer Dorothea Kofahl-Krause Norbert Niederle Gerhard Heil Christoph Losem Manfred Welslau Wolfram Brugger Ulrich Germing Ralf Kronenwett Juergen Barth Mathias J Rummel Rainer Haas Guido Kobbe

Blood 2015 Sep 3;126(12):1407-14. Epub 2015 Aug 3.

University Hospital Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, Germany;

View Article

Download full-text PDF

 Source
http://www.bloodjournal.org/content/early/2015/08/03/blood-2
Web Search
http://www.bloodjournal.org/content/126/12/1407.full.pdf
Web Search
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2015-03-63
Publisher Site
http://dx.doi.org/10.1182/blood-2015-03-630012DOI Listing
September 2015

5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study.

Authors:
J Randolph Hecht Edith P Mitchell Takayuki Yoshino Manfred Welslau Xun Lin Edna Chow Maneval Jolanda Paolini Maria Jose Lechuga Albrecht Kretzschmar

Cancer Manag Res 2015 15;7:165-73. Epub 2015 Jun 15.

Klinikum St Georg, Leipzig, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.2147/CMAR.S61408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474399PMC
June 2015

Trastuzumab in advanced breast cancer--a decade of experience in Germany.

Authors:
Christian Jackisch Winfried Schoenegg Dietmar Reichert Manfred Welslau Johannes Selbach Hanns-Detlev Harich Hans Tesch Tim Wohlfarth Heidi Eustermann Axel Hinke

BMC Cancer 2014 Dec 8;14:924. Epub 2014 Dec 8.

Department of Obstetrics and Gynaecology and Breast Cancer Center, Sana Klinikum Offenbach GmbH, Starkenburgring 66, D-63060 Offenbach, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1186/1471-2407-14-924DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295514PMC
December 2014

Patient-reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T-DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2-positive locally advanced or metastatic breast cancer.

Authors:
Manfred Welslau Veronique Diéras Joo-Hyuk Sohn Sara A Hurvitz Deepa Lalla Liang Fang Betsy Althaus Ellie Guardino David Miles

Cancer 2014 Mar 12;120(5):642-51. Epub 2013 Nov 12.

Medical Office Hematology, Aschaffenburg, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/cncr.28465DOI Listing
March 2014

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.

Authors:
Mathias J Rummel Norbert Niederle Georg Maschmeyer G Andre Banat Ulrich von Grünhagen Christoph Losem Dorothea Kofahl-Krause Gerhard Heil Manfred Welslau Christina Balser Ulrich Kaiser Eckhart Weidmann Heinz Dürk Harald Ballo Martina Stauch Fritz Roller Juergen Barth Dieter Hoelzer Axel Hinke Wolfram Brugger

Lancet 2013 Apr 20;381(9873):1203-10. Epub 2013 Feb 20.

Medizinische Klinik IV, Hospital of the Justus-Liebig-University, Giessen, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S0140-6736(12)61763-2DOI Listing
April 2013

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Authors:
Sunil Verma David Miles Luca Gianni Ian E Krop Manfred Welslau José Baselga Mark Pegram Do-Youn Oh Véronique Diéras Ellie Guardino Liang Fang Michael W Lu Steven Olsen Kim Blackwell

N Engl J Med 2012 Nov 1;367(19):1783-91. Epub 2012 Oct 1.

Sunnybrook Odette Cancer Centre, Toronto, ON M4N 3M5, Canada.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1056/NEJMoa1209124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125250PMC
November 2012

Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.

Authors:
Mathias J Rummel Salah E Al-Batran Soo-Z Kim Manfred Welslau Ralf Hecker Dorothea Kofahl-Krause Klaus-M Josten Heinz Dürk Andreas Rost Michael Neise Ulrich von Grünhagen Kai U Chow Martin-L Hansmann Dieter Hoelzer Paris S Mitrou

J Clin Oncol 2005 May;23(15):3383-9

Med. Klinik II, Johann Wolfgang Goethe-Universitätsklinik, Frankfurt/Main, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2005.08.100DOI Listing
May 2005